96 related articles for article (PubMed ID: 7054288)
1. Mouse brain: an immunologically privileged site for natural resistance against lymphoma cells.
Circolo A; Bianchi R; Nardelli B; Rivosecchi-Merletti P; Bonmassar E
J Immunol; 1982 Feb; 128(2):556-62. PubMed ID: 7054288
[No Abstract] [Full Text] [Related]
2. [Experimental analysis of intracerebral natural resistance against H-2+ and H-2- lymphomas grafted into the brain].
Yamasaki T; Kikuchi H; Yamashita J; Ljunggren HG; Karre K; Klein G
No Shinkei Geka; 1989 Aug; 17(8):717-23. PubMed ID: 2586713
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of lymphoma growth in the spleen and liver of lethally irradiated mice.
Iorio A; Campanile F; Neri M; Spreafico F; Goldin A; Bonmassar E
J Immunol; 1978 May; 120(5):1679-85. PubMed ID: 659871
[No Abstract] [Full Text] [Related]
4. Immunological response in the mouse brain: I. Transplantation immunity to mouse lymphoma graft.
Keyaki A; Handa H; Yamashita J; Kuribayashi K; Masuda T
Nihon Geka Hokan; 1988 May; 57(3):191-201. PubMed ID: 3248016
[No Abstract] [Full Text] [Related]
5. Immunogenetic studies on the resistance of mice to highly metastatic DBA/2 tumor cell variants. I. Effect of incompatibilities at H-2 or non-H-2 genes in normal and nude (nu/nu) mice.
Schirrmacher V
Invasion Metastasis; 1981; 1(1):4-21. PubMed ID: 7188381
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the YC8 lymphoma growth by alloimmunization with normal cells.
Parmiani G; Sensi ML
Transplant Proc; 1981 Dec; 13(4):1906-9. PubMed ID: 7330975
[No Abstract] [Full Text] [Related]
7. Radioresistant inhibition of lymphoma growth in congenitally athymic (nude) mice.
Campanile F; Crino L; Bonmassar E; Houchens D; Goldin A
Cancer Res; 1977 Feb; 37(2):394-8. PubMed ID: 832264
[TBL] [Abstract][Full Text] [Related]
8. Immunological response in the mouse brain: II. Experimental immunotherapy model against transplanted mouse lymphoma in the brain.
Keyaki A; Handa H; Yamashita J; Kuribayashi K; Masuda T
Nihon Geka Hokan; 1988 May; 57(3):202-14. PubMed ID: 3266837
[No Abstract] [Full Text] [Related]
9. On the immunocompetence of H-2 incompatible irradiation bone marrow chimeras.
Zinkernagel RM; Althage A; Callahan G; Welsh RM
J Immunol; 1980 May; 124(5):2356-65. PubMed ID: 6444970
[No Abstract] [Full Text] [Related]
10. Cyclical changes in susceptibility of a myeloma tumor (LPC-1) to immune destruction. II. Periodic fluctuations during growth in normal and nude mice and in culture.
Hale AH; Celis E; Russell JH; Eisen HN
J Immunol; 1979 Mar; 122(3):959-64. PubMed ID: 312829
[No Abstract] [Full Text] [Related]
11. Growth of P511 mastocytoma cells in BALB/c mouse brain elicits CTL response without tumor elimination: a new tumor model for regional central nervous system immunity.
Gordon LB; Nolan SC; Cserr HF; Knopf PM; Harling-Berg CJ
J Immunol; 1997 Sep; 159(5):2399-408. PubMed ID: 9278331
[TBL] [Abstract][Full Text] [Related]
12. Specific graft-versus-host nonreactivity of lymphoid cells from irradiation chimeras.
Norin AJ; Emeson EE; Veith FJ
Transplant Proc; 1981 Mar; 13(1 Pt 2):1241-4. PubMed ID: 7268889
[No Abstract] [Full Text] [Related]
13. Variation in histocompatibility antigen expression on murine tumors: differences in expression and immunogenicity of H-2K region-coded unique antigens.
Imamura M; Martin WJ
J Immunol; 1982 Aug; 129(2):877-81. PubMed ID: 7086147
[No Abstract] [Full Text] [Related]
14. [Ultradian fluctuations in the natural antitumor resistance of mice undergoing transplantation and chemical carcinogenesis].
Suslov AP; Riabykh TP; Slavina EG; Kasatkina NN; Leĭpunskaia IL
Tsitologiia; 1987 Jan; 29(1):79-85. PubMed ID: 3564161
[TBL] [Abstract][Full Text] [Related]
15. Unexpected reaction of anti-H-2d serum with thymic lymphoma cells derived from transgenic B6-H-2b TCR anti-HY/Db mice.
Matuszyk J; Zioło E; Kobzdej M; Strzadala L
Arch Immunol Ther Exp (Warsz); 1996; 44(2-3):103-7. PubMed ID: 8915513
[TBL] [Abstract][Full Text] [Related]
16. A new minor histocompatibility locus linked to H-3.
Click RE; Schneider D; Roopenian DC
J Immunol; 1981 Jun; 126(6):2378-81. PubMed ID: 7229381
[TBL] [Abstract][Full Text] [Related]
17. Origin and function of suppressor macrophages in myeloma.
Kennard J; Zolla-Pazner S
J Immunol; 1980 Jan; 124(1):268-73. PubMed ID: 6965292
[No Abstract] [Full Text] [Related]
18. [Appearance of new transplantation antigens in tumor cells treated with RNA].
Nikolin VP; Il'nitskaia SI; Gruntenko EV; Tomsons VP
Eksp Onkol; 1984; 6(1):42-7. PubMed ID: 6209090
[TBL] [Abstract][Full Text] [Related]
19. Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism.
Ljunggren HG; Kärre K
J Exp Med; 1985 Dec; 162(6):1745-59. PubMed ID: 3877776
[TBL] [Abstract][Full Text] [Related]
20. Source of tumor cells influences their immune recognition by H-2-matched mice.
Forni G; Varesio L; Giovarelli M; Landolfo S
Transplantation; 1979 Jun; 27(6):433-5. PubMed ID: 462530
[No Abstract] [Full Text] [Related]
[Next] [New Search]
